Fresh Rounds

FibroBiologics, Inc. funding

FibroBiologics, Inc., a pharmaceuticals company based in Houston, TX (founded 2021), filed a Form D with the SEC on October 13, 2026 and reported $1.2M raised. It filed 6 new offerings in this period, totaling $11.9M.

Amount raised$1.2M
Offering size$1.2M
Filed with the SECOctober 13, 2026
First saleOctober 7, 2026
IndustryPharmaceuticals
SecuritiesEquity, Debt, Options or warrants, Security to be acquired on exercise
LocationHouston, TX
Founded2021
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose

All filings

FiledRaisedOfferingSecurities
October 13, 2026$1.2M$1.2MEquity, Debt, Options or warrants, Security to be acquired on exercise
September 16, 2026$500K$500KEquity, Options or warrants, Security to be acquired on exercise
June 29, 2026$3M$3MOptions or warrants, Security to be acquired on exercise
December 16, 2025$1.7M$1.7MEquity, Options or warrants, Security to be acquired on exercise
December 3, 2025$4M$4MEquity, Options or warrants, Security to be acquired on exercise
December 3, 2025$1.5M$1.5MEquity, Options or warrants, Security to be acquired on exercise

Other health care rounds in Texas